Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Press Releases

  • 12/10/2014

    PDA Announces Board of Directors Election Results

    The Parenteral Drug Association (PDA) announced today the results of its 2014 Board of Directors election. PDA members voted for four volunteer directors over a period of three months this past fall.
  • 12/05/2014

    PDA Pharmaceutical Quality Metrics Conference Offered Industry and U.S. FDA a Forum to Discuss Future Risk-Based Inspection Program

    Washington, D.C. (December 4, 2014) – The Parenteral Drug Association (PDA) today closed its second annual Pharmaceutical Quality Metrics Conference with panels of distinguished representatives of pharmaceutical companies and officials from the U.S. FDA, the European Medicines Agency and the UK's regulatory body for medical products. Nearly all of the conferences 250 attendees remained engaged through the final panel discussions Thursday.
  • 10/28/2014

    PDA Publishes Pharma. Quality Metrics Definitions in Points to Consider Paper

    Bethesda, Md., October 27, 2014 Year – The Parenteral Drug Association (PDA) published definitions for four key quality metrics in an updated version of its “Points to Consider: Pharmaceutical Quality Metrics,” which was first published independently in December 2013.
  • 10/16/2014

    PDA Offers Help in Applying Single Use Systems to Bio/Pharma Operations

    Bethesda, Md., October 16, 2014 – The Parenteral Drug Association (PDA) announces the completion of guidance on the application of single-use, or disposable , systems in the manufacturing operations for pharmaceutical and biopharmaceutical products with the publication of Technical Report No. 66: Application of Single-Use Systems in Pharmaceutical Manufacturing.
  • 09/22/2014

    PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols

    Bethesda, Md., September 19, 2014 – The Parenteral Drug Association (PDA) is moving forward with an initiative to harmonize global post-approval changes protocols.
  • 09/10/2014

    PDA Announces Development of Technical Report on Prevention and Management of Drug Shortages

    Washington, DC, September 9, 2014 – The Parenteral Drug Association (PDA) today announced its plans to publish a Technical Report on the prevention and management of drug shortages. Regulators in the United States and Europe have been reaching out to industry to find ways to mitigate the kinds of shortages driven by manufacturing disruptions resulting from quality problems and regulatory enforcement activities.
  • 09/08/2014

    PDA Opens Quality Culture Survey

    Bethesda, Md., September 5, 2014 – The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator’s risk-based inspection programs.
  • 07/24/2014

    PDA Training and Research Institute Adds 31 Courses to GSA Schedule

    Bethesda, Md., July 24, 2014 – The Parenteral Drug Association (PDA) announced today that 31 of its Training and Research Institute (TRI) courses are now listed with the U.S. General Services Administration (GSA) under a Federal Supply Schedule contract.
  • 07/17/2014

    FDA Acting Chief Scientist Ostroff to Speak at the 2014 PDA/FDA Joint Regulatory Conference

    Bethesda, Md., July, 16 2014 – The Parenteral Drug Association (PDA) has confirmed FDA’s Stephen Ostroff, M.D., Acting Chief Scientist in the Office of the Commissioner will present “FDA’s Views on Scientific Advances and their Impact on Manufacturing of the Future” on September 8, 2014 in at the opening plenary session of the 2014 PDA/FDA Joint Regulatory Conference in Washington, DC at the Renaissance Hotel.
  • 06/18/2014

    CDER Director Woodcock, 27 U.S. FDA Speakers Confirmed for 2014 PDA/FDA Joint Regulatory Conference

    Bethesda, Md., June 18, 2014 – The Parenteral Drug Association has confirmed the participation of 27 officials from the U.S. FDA, including CDER Director Janet Woodcock, MD, as speakers at the 2014 PDA/FDA Joint Regulatory Conference.
  • 05/06/2014

    PDA Announces Participation of Four FDA Speakers for 2014 PDA/FDA Virus & TSE Safety Conference

    Bethesda, Md., April 21, 2014 – The Parenteral Drug Association (PDA) announced today that it has confirmed the participation of four experts from the U.S. FDA in the upcoming 2014 PDA/FDA Virus and TSE Safety Conference, June 12-13, 2014, at the Hyatt Regency Hotel, Bethesda, Maryland.
  • 04/29/2014

    Four U.S. FDA Supply Chain Experts to Answer Industry Questions at PDA Conference

    Bethesda, Md., April 21, 2014 – The Parenteral Drug Association (PDA) announced today that it has confirmed the participation of four experts from the U.S. FDA in the upcoming 2014 PDA/FDA Pharmaceutical Supply Chain Conference, June 3-4, 2014, at the JW Marriott in Washington, DC.
  • 04/04/2014

    Nominations Being Accepted for PDA Board of Directors

    Bethesda, Md., April 4, 2014 – The Parenteral Drug Association (PDA) announced the opening of the nomination process for Board members for the 2015-2017 term.
  • 02/19/2014

    PDA Announces Opening Plenary Speakers for the 2014 Annual Meeting

    Bethesda, Md., February 18, 2014 – The Parenteral Drug Association (PDA) is proud to announce that Dr. Mark B. McClellan, Director, Health Care Innovation and Value Initiative for the Brookings Institute and former FDA Commissioner and Dr. Rahul Singhvi, Chief Operating Officer, Vaccines, Takeda Pharmaceuticals International will be the Opening Plenary Speakers at the 2014 PDA Annual Meeting, April 7-9, JW Marriott San Antonio Hilly Country Resort & Spa in San Antonio, Texas.